VRS
ITOS

Virginia Retirement Systems’s iTeos Therapeutics ITOS Stock Holding History

Virginia Retirement Systems’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$308K Sell
28,100
-13,900
-33% -$178K ﹤0.01% 802
2023
Q2 		$556K Buy
42,000
+2,100
+5% +$29.9K 0.01% 699
2023
Q1 		$543K Sell
39,900
-4,100
-9% -$73.5K 0.01% 716
2022
Q4 		$859K Buy
44,000
+1,000
+2% +$19.5K 0.01% 647
2022
Q3 		$819K Buy
+43,000
New +$991K 0.01% 640

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virginia Retirement Systems's ITOS Position: Q3 2023 in Review

Virginia Retirement Systems reduced its iTeos Therapeutics (ITOS) stake by 33% in Q3 2023, selling an estimated $178K and leaving 28,100 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #802.

Virginia Retirement Systems first reported a position in ITOS in Q3 2022 and has held it in 5 quarters since. The position peaked at $859K in Q4 2022. 144 funds tracked by Wall St. Rank hold ITOS as of Q3 2023.

  • Virginia Retirement Systems held 28,100 shares of iTeos Therapeutics worth $308K as of Q3 2023.
  • Virginia Retirement Systems sold 13,900 iTeos Therapeutics shares in Q3 2023, an estimated $178K.
  • iTeos Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #802 holding.
  • Virginia Retirement Systems first reported a position in iTeos Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • Virginia Retirement Systems's iTeos Therapeutics position peaked at $859K in Q4 2022.
  • 144 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.